DK0861837T3 - Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0861837T3
DK0861837T3 DK98400469T DK98400469T DK0861837T3 DK 0861837 T3 DK0861837 T3 DK 0861837T3 DK 98400469 T DK98400469 T DK 98400469T DK 98400469 T DK98400469 T DK 98400469T DK 0861837 T3 DK0861837 T3 DK 0861837T3
Authority
DK
Denmark
Prior art keywords
alkyl
aminoindan
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK98400469T
Other languages
Danish (da)
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0861837T3 publication Critical patent/DK0861837T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98400469T 1997-02-27 1998-02-27 Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK0861837T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0861837T3 true DK0861837T3 (da) 2004-08-16

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98400469T DK0861837T3 (da) 1997-02-27 1998-02-27 Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (19)

Country Link
US (1) US5968954A (zh)
EP (1) EP0861837B1 (zh)
JP (1) JPH10237071A (zh)
CN (1) CN1090627C (zh)
AT (1) ATE265451T1 (zh)
AU (1) AU725756B2 (zh)
BR (1) BR9800763A (zh)
CA (1) CA2231025C (zh)
DE (1) DE69823411T2 (zh)
DK (1) DK0861837T3 (zh)
ES (1) ES2219853T3 (zh)
FR (1) FR2760014B1 (zh)
HK (1) HK1014945A1 (zh)
HU (1) HU224312B1 (zh)
NO (1) NO314307B1 (zh)
NZ (1) NZ329853A (zh)
PL (1) PL190240B1 (zh)
PT (1) PT861837E (zh)
ZA (1) ZA981680B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
KR20080079341A (ko) * 2001-01-16 2008-08-29 아스트라제네카 아베 치료용 헤테로시클릭 화합물
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
WO2006062063A1 (ja) * 2004-12-08 2006-06-15 Astellas Pharma Inc. ピペリジン誘導体及びその製造法
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
HU224312B1 (hu) 2005-07-28
AU5635998A (en) 1998-09-03
PL190240B1 (pl) 2005-11-30
DE69823411T2 (de) 2005-02-17
CN1194983A (zh) 1998-10-07
NO314307B1 (no) 2003-03-03
HU9800422D0 (en) 1998-04-28
NO980803D0 (no) 1998-02-26
ATE265451T1 (de) 2004-05-15
PL324982A1 (en) 1998-08-31
HUP9800422A1 (hu) 1999-12-28
ES2219853T3 (es) 2004-12-01
US5968954A (en) 1999-10-19
AU725756B2 (en) 2000-10-19
EP0861837A1 (fr) 1998-09-02
ZA981680B (en) 1998-09-04
CA2231025A1 (fr) 1998-08-27
CN1090627C (zh) 2002-09-11
CA2231025C (fr) 2003-09-16
HK1014945A1 (en) 1999-10-08
EP0861837B1 (fr) 2004-04-28
NO980803L (no) 1998-08-28
NZ329853A (en) 1999-01-28
JPH10237071A (ja) 1998-09-08
FR2760014B1 (fr) 1999-04-09
DE69823411D1 (de) 2004-06-03
PT861837E (pt) 2004-07-30
FR2760014A1 (fr) 1998-08-28
BR9800763A (pt) 1999-12-07

Similar Documents

Publication Publication Date Title
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
FR2654104B1 (fr) Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2091834T3 (es) Compuestos aromaticos.
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
MX9204137A (es) Derivados de 5-aril-isoxazol, composicion herbicida que los contiene y procedimiento para su preparacion.
CO5011090A1 (es) Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos
ES530901A0 (es) Procedimiento para preparar derivados de piperazina
DK0861837T3 (da) Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
HRP20000508B1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
ES2167853T3 (es) N-aril 2-hidroxi alquilamidas.
NO975121L (no) Nye heterocykliske aminometylforbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
NO973442D0 (no) Nye bismidforbindelser, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger inneholdende slike
NO981566L (no) Nye aminoforbindelser av 6,7,8,9-tetrahydro-cyklopenta[a]naftalen og av 2,3-dihydro-cyklopenta[e]inden, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger som inneholder dem
HUP9800687A1 (hu) N-aril-piperidin-származékok, eljárás előállításukra, és e vegyületeket tartalmazó gyógyszerkészítmények